The stock is in a sustained uptrend over the past year, evidenced by a 56.93% 1-year price change. With a current price of $95.27, it is trading at approximately 76% of its 52-week range ($60.33 to $106.98), positioning it closer to the upper bound, which suggests strong momentum but also raises questions about potential overextension after such a significant rally. Recent short-term momentum shows deceleration from the longer-term trend; the stock gained 6.67% over the last 3 months but only 6.59% over the past month, indicating a consolidation phase near recent highs after a sharp run-up in February. This divergence, where the 1-month return is significantly lower than the 1-year return, signals a potential pause or pullback as the stock digests its gains, a view supported by its negative 1-month relative strength of -3.39 against the SPY. Key technical support is anchored at the 52-week low of $60.33, while immediate resistance sits at the 52-week high of $106.98. A decisive breakout above $107 would signal a resumption of the primary bull trend, whereas a breakdown below the recent consolidation range around $90 could indicate a deeper correction. The stock exhibits below-market volatility with a beta of 0.544, meaning it has historically been about 46% less volatile than the SPY, which is notable for a consumer cyclical name and suggests a lower risk profile for position sizing, though recent price swings indicate idiosyncratic event-driven volatility.

Revenue growth has been volatile but showed a significant rebound in the latest quarter; Q4 2025 revenue was $1.446 billion, representing a robust 31.25% year-over-year growth, a sharp acceleration from the prior year's Q4 revenue of $1.102 billion. This positive trend is a key recovery signal, though it follows a period of instability including a weak Q2 2025 where revenue was only $980.8 million, indicating the growth trajectory is not yet smooth and remains quarter-dependent. Profitability has been inconsistent, with the company posting a net income of $201.6 million in Q4 2025, a strong turnaround from a net loss of $34.3 million in the year-ago quarter. The gross margin remains healthy at 68.95% for Q4 2025, consistent with its high-margin brand and licensing model, and the operating margin was 22.5% according to valuation data, demonstrating core operational strength when excluding one-time charges like the significant $1.038 billion 'other expenses' hit in Q2 2025 that led to an $855.8 million net loss. The balance sheet shows elevated financial leverage with a debt-to-equity ratio of 6.32, indicating a heavily debt-funded capital structure, which is a key risk factor. However, liquidity is adequate with a current ratio of 1.38, and the company is generating substantial cash, with trailing twelve-month free cash flow of $829.9 million, providing it with internal resources to service debt and fund operations. The return on equity is deeply negative at -59.87%, primarily distorted by the large Q2 loss and high debt load, masking the underlying cash-generating ability of the business.